Global Cord Blood Corporation

Equities

CORBF

KYG393421030

Healthcare Facilities & Services

Market Closed - OTC Markets 03:26:59 2024-04-12 pm EDT 5-day change 1st Jan Change
1.25 USD -3.85% Intraday chart for Global Cord Blood Corporation -3.85% +2.46%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Global Cord Blood Corporation Announces Board Appointments CI
Global Cord Blood Corporation(NYSE:CO) dropped from S&P Global BMI Index CI
Global Cord Blood Corporation Announces Board Changes CI
China Cord Blood Posts Lower Fiscal Q4 Profit, Revenue MT
Global Cord Blood Corporation Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Earnings Flash (CO) GLOBAL CORD BLOOD CORPORATION Posts Q4 EPS $0.14 MT
Global Cord Blood Corporation Reports Earnings Results for the Fourth Quarter Ended March 31, 2022 CI
Global Cord Blood Shares Rise 15% After Merger Target Gets FDA Clearance for IND DJ
Global Cord Says Cellenkos Gets US FDA OK of IND Application for CK0804 as Add-on Therapy to Ruxolitinib for Myelofibrosis MT
Global Cord Blood Corporation Approves Board Changes CI
Global Cord Blood Shareholder Blue Ocean Says EGM Called to Vote on Cellenkos Deal Cancelation Proposal MT
Global Cord Blood Corporation Proposes Board Changes CI
Global Cord Blood Corporation (NYSE:CO) cancelled the acquisition of an unknown stake in Cellenkos, Inc. from Leong Kim Chuan. CI
Blue Ocean Structure Provides Information to Shareholders of Global Cord CI
Blue Ocean Structure Investment Company Limited Communicates with Global Cord Blood Corporation CI
Blue Ocean Structure Investment Company Limited Sues Global Cord Blood Corporation CI
China Cord Blood's Stock Down 35%; Announces Acquisition of Cellenkos MT
Global Cord Blood Corporation (NYSE : CO) entered into an agreement to acquire an unknown stake in Cellenkos, Inc. from Leong Kim Chuan. CI
Transcript : Global Cord Blood Corporation, Q3 2022 Earnings Call, Mar 01, 2022
Global Cord Blood Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Health Care Stocks Point Lower Premarket Friday MT
Global Cord Blood Rejects Takeover Bid From Alternate Ocean Investment MT
Unknown buyers cancelled the acquisition of Global Cord Blood Corporation (NYSE:CO) from Blue Ocean Structure Investment Company Ltd. and others. CI
Transcript : Global Cord Blood Corporation, Q2 2022 Earnings Call, Nov 26, 2021
Global Cord Blood Corporation Posts Lower Q2 Profit Amid Higher Revenue -- Stock Up 2% After-Hours MT
Chart Global Cord Blood Corporation
More charts
Global Cord Blood Corporation is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. It also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The Company provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. It also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants.
More about the company
  1. Stock Market
  2. Equities
  3. CORBF Stock
  4. News Global Cord Blood Corporation
  5. Global Cord Blood : China Cord Blood Receives $5 per Share Takeover Bid From Haitong International Securities Group Unit